Latest
-
Precision Cancer Medicines for Colon Cancer
Genomic testing identifies genetic targets that can be treated with precision cancer medicines avoiding chemotherapy
-
FDA Approves New First-Line Treatment Options for HER2-Positive AdvancedGastric and GEJ Cancer
The FDA has approved new first-line zanidatamab-based treatment options for certain people with HER2-positive advanced stomach, gastroesophageal junction, and esophageal cancers. In a major clinical trial, the combination of zanidatamab, tislelizumab, and chemotherapy extended survival and delayed cancer progression compared with trastuzumab plus chemotherapy. Learn who may be eligible, what HER2 testing means, and key…
Welcome to CancerConnect
CancerConnect is a unique resource that brings patients, caregivers, advocates and experts together – individuals benefit from a blend of expert-authored news and educational programming alongside a robust social network, providing insight into symptoms, diagnosis, and treatment and the support of other individuals being treated at some of the best cancer centers. CancerConnect offers users expert authored clinically-reviewed information and the perspective of their peers in a safe, objective space, helping to ensure they become empowered in their healthcare journey. Search the over 7000 articles on the management of cancer.
